Intimation Of Board meeting under regulation 29(1)(d) of SEBI (LODR)Regulation,2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences has informed BSE about a Board Meeting scheduled on June 25, 2025 at 4:00 PM at its corporate office in New Delhi. The agenda includes approving the notice for an Extra-Ordinary General Meeting (EGM) and related matters. The Board will also consider appointing an Additional Director under Section 161(1) of the Companies Act, 2013. Additionally, the appointment or re-appointment of the Cost Auditor for financial year 2025-26 will be discussed. No financial results are being considered in this meeting.
This is a routine board meeting intimation. Shareholders should watch for the outcome of the EGM notice and the new director appointment, as these could signal changes in board composition or governance. No immediate impact on stock price is expected.